Image (Image 01)
Diltiazem Hydrochloride Capsule, Extended Release
Product Images NDC 71335-2089
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Diltiazem Hydrochloride (NDC 71335-2089). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Product Images & Figures Index
Image (Image 02)
This is a report on a clinical trial that combined placebo-controlled trials for angina and hypertension using Diltiazem hydrochloride extended-release capsules. The table provided shows the adverse reactions experienced by the study participants, including headache, dizziness, bradycardia, AV block, first degree, edema, and asthenia.*
Label (Lbl713352089)
This is a description of a medication packaging labeled as Diltiazem HCI ER. The medication comes in a white capsule with a dosage of 120mg. The packaging includes instructions to keep it tightly closed and to store it at room temperature. It also warns to keep all medications out of reach of children. The manufacturer of the medication is Ingenus Pharmaceuticals LLC. The label includes information such as NDC number, lot number, and expiration date.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
